Tagged with blockchain

Global Merck Group’s Vice President Global Market Access & Pricing Strategic Planning Marco Rauland casts his eye over blockchain-based smart contracts and their applications for pharma across supply chain enhancement, improving clinical trials, and outcome-based contracting.   Smart contracts are self-executing digital contracts based on blockchain technology that provides decentralized data…

Taiwan Carol Cheng, chief operating officer of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), gives an update on the current condition of Taiwan’s biopharma environment and speaks about the country’s innovative capacity as an industry leader not only in the region but globally.   In total, there are 295 Taiwan new…

AI Axel Schumacher highlights the vital importance of AI and blockchain for the future success of pharmaceutical companies, the significant knowledge gap that currently exists within Big Pharma, and why, therefore, now is the time for these firms to invest in AI and blockchain start-ups.   While almost everyone is talking…

Trends As we move further into 2019, Emmanuel Fombu, MD, MBA: Author and Global Commercial Strategy and Digital Innovation Leader at Johnson and Johnson, reflects on what to expect from the rest of the year and beyond in the pharmaceutical landscape. The battle for market share in the future will likely…

Opinion Emmanuel Fombu, Global Strategy and Digital Innovation Leader at Johnson & Johnson reflects on health professionals’ fears of AI and their place in the healthcare workforce of the future. Sure, robots might be better at carrying out specific operations or at carrying out monotonous tasks without tiring, but it’s the…

Opinion Mohamed is a passionate Blockchain enthusiast who is committed to helping grow the Blockchain ecosystem around the world. Here he talks about healthcare’s slow adoption of technology and the challenges that come with hefty privacy regulation of patient data.  The life-and-death nature of the industry might be a factor of…

Innovation Joonho J. Lee is a CEO and CoFounder of Cognita Lab INC developing risk management framework around Artificial Intelligence (AI) in healthcare and financial services industries. Here he discusses the use of blockchain in the healthcare industry and the need to remain “cautiously optimistic.”   Many people asked whether I…

Innovation Richie Etwaru is founder and CEO of Hu-manity, whose vision is to empower people to take ownership of their inherent human data.   The pharmaceutical industry has never seen the full end-to-end benefits of a world where explicitly consented data is available. And this can happen without disruption. Everyone can indeed…

Innovation Axel Schumacher, co-founder and Chief Scientific Officer of Shivom, highlights the need for Big Pharma to adopt new technology. Of course, we know that pharma is often innovation-averse. The healthcare industry has been full of disruptions in the last decade, ranging from the explosive growth of medical devices and the…

Innovation “Imagine a world where every single ingredient inside every single pharmaceutical you take is traced from start to finish.” We can all agree that the healthcare system in the United States is in dire need of an overhaul. Technological advances propel us into the 21st Century, but the way data…

Pharma In May 2018, PharmaBoardroom’s readers were asked what they felt were the biggest new sources of disruption to the traditional pharma industry today. Options included 3D Bioprinting, blockchain storage, genomics and artificial intelligence. 3D Bioprinting As Figure 1 (below) shows, 11 percent of our survey respondents felt that 3D bioprinting…

Taiwan Deputy Minister for Science and Technology on Taiwan Fong Chin Su gives his insights on innovation, cybersecurity, and the current state of one of the world’s most exciting biotech industries.   Taiwan’s history with biotech only shows 10 years of focused development. The government is committed to an innovative economy…